Is It a Supplementary Benefit to Use Anti-Inflammatory Agents in the Treatment of Type 2 Diabetes?

BMC Research Notes - United Kingdom
doi 10.1186/s13104-017-2785-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

Type-2 Diabetes Mellitus Is It Habitat Specific?

IOSR Journal of Pharmacy and Biological Sciences
2014English

Steroid-Induced Diabetes: Is It Just Unmasking of Type 2 Diabetes?

ISRN Endocrinology
2012English

Prevention of Type 2 Diabetes: What Is It Really?

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Why It Is Important to Know the Diabetes Type?

Kansas Journal of Medicine
2009English

Is Weight Loss the Future of Type 2 Diabetes Treatment?

Prescriber
Pharmacology
2018English

Cost–benefit Comparison of Liraglutide and Sitagliptin in the Treatment of Type 2 Diabetes in Thailand

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Approaches to Treatment of Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Lixisenatide: Evidence for Its Potential Use in the Treatment of Type 2 Diabetes

Core Evidence
MedicineReviewsReferencesPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy